SCHEMBL21787618

SCHEMBL21787618

CNC(=O)COc1cc2cc([N+](=O)[O-])c(OC)cc2n(C)c1=O

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BCL6 P41182 8/20 0.42
MELK Q14680 1/20 0.41
TDP1 Q9NUW8 1/20 0.40
NCOR2 Q9Y618 4/20 0.40
NQO2 P16083 1/20 0.40
MTNR1A P48039 1/20 0.40
MTNR1B P49286 1/20 0.40
SMN1; SMN2 Q16637 3/20 0.39
ALDH1A1 P00352 1/20 0.39
NPC1 O15118 2/20 0.39
RAB9A P51151 2/20 0.39
MAPT P10636 3/20 0.38
MEN1 O00255 1/20 0.38
KMT2A Q03164 1/20 0.38
LMNA P02545 2/20 0.37
KDM4E B2RXH2 1/20 0.37
HTT P42858 1/20 0.37
NPSR1 Q6W5P4 1/20 0.37
CHRM4 P08173 1/20 0.37
BCL6B Q8N143 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20267661 0.87 BCL6 (0.47) BCL6MELKTDP1NCOR2SMN1; SMN2
SCHEMBL21787569 0.87 BCL6 (0.42) BCL6MELKNCOR2SMN1; SMN2ALDH1A1
SCHEMBL20284512 0.82 BCL6 (0.44) BCL6MELKNCOR2SMN1; SMN2ALDH1A1
SCHEMBL20267284 0.81 BCL6 (0.49) BCL6MELKTDP1NCOR2SMN1; SMN2
SCHEMBL29874501 0.81 BCL6 (0.49) BCL6MELKTDP1NCOR2SMN1; SMN2
SCHEMBL21774715 0.79 BCL6 (0.49) BCL6SMN1; SMN2ALDH1A1MAPTMEN1
SCHEMBL21787696 0.77 TDP1 (0.49) TDP1NQO2MTNR1AMTNR1BSMN1; SMN2
SCHEMBL22421736 0.75 TDP1 (0.50) TDP1NQO2MTNR1AMTNR1BSMN1; SMN2
SCHEMBL23267671 0.74 BCL6 (0.55) BCL6MELKTDP1NCOR2MAPT
SCHEMBL20267506 0.73 BCL6 (0.50) BCL6MELKNCOR2SMN1; SMN2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11001570-B2 6-amino-quinolinone compounds and derivatives as BCL6 inhibitors BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2021-05-11 US disclosed
US-20200071297-A1 NEW 6-AMINO-QUINOLINONE COMPOUNDS AND DERIVATIVES AS BCL6 INHIBITORS BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG (DE) 2020-03-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200071297-A1 NEW 6-AMINO-QUINOLINONE COMPOUNDS AND DERIVATIVES AS BCL6 INHIBITORS BCL6, BCL6B, BCOR BCL6 1/4885MELK 393/4885TDP1 2887/4885
US-11001570-B2 6-amino-quinolinone compounds and derivatives as BCL6 inhibitors BCL6, BCL6B, BCOR BCL6 1/4885MELK 366/4885TDP1 3322/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.